Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
13 04 2021
Historique:
entrez: 13 4 2021
pubmed: 14 4 2021
medline: 23 4 2021
Statut: ppublish

Résumé

Vitamin D is a fat-soluble vitamin that performs an important role in calcium homeostasis and bone metabolism and also affects many other cellular regulatory functions outside the skeletal system. Vitamin D requirements may vary by individual; thus, no one serum vitamin D level cutpoint defines deficiency, and no consensus exists regarding the precise serum levels of vitamin D that represent optimal health or sufficiency. To update its 2014 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on screening for vitamin D deficiency, including the benefits and harms of screening and early treatment. Community-dwelling, nonpregnant adults who have no signs or symptoms of vitamin D deficiency or conditions for which vitamin D treatment is recommended. The USPSTF concludes that the overall evidence on the benefits of screening for vitamin D deficiency is lacking. Therefore, the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults cannot be determined. The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (I statement).

Identifiants

pubmed: 33847711
pii: 2778487
doi: 10.1001/jama.2021.3069
doi:

Substances chimiques

Vitamins 0
Vitamin D 1406-16-2
25-hydroxyvitamin D A288AR3C9H

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

1436-1442

Commentaires et corrections

Type : CommentIn

Auteurs

Alex H Krist (AH)

Fairfax Family Practice Residency, Fairfax, Virginia.
Virginia Commonwealth University, Richmond.

Karina W Davidson (KW)

Feinstein Institute for Medical Research at Northwell Health, New York, New York.

Carol M Mangione (CM)

University of California, Los Angeles.

Michael Cabana (M)

Albert Einstein College of Medicine, New York, New York.

Aaron B Caughey (AB)

Oregon Health & Science University, Portland.

Esa M Davis (EM)

University of Pittsburgh, Pittsburgh, Pennsylvania.

Katrina E Donahue (KE)

University of North Carolina at Chapel Hill.

Chyke A Doubeni (CA)

Mayo Clinic, Rochester, Minnesota.

John W Epling (JW)

Virginia Tech Carilion School of Medicine, Roanoke.

Martha Kubik (M)

George Mason University, Fairfax, Virginia.

Li Li (L)

University of Virginia, Charlottesville.

Gbenga Ogedegbe (G)

New York University, New York, New York.

Douglas K Owens (DK)

Stanford University, Stanford, California.

Lori Pbert (L)

University of Massachusetts Medical School, Worcester.

Michael Silverstein (M)

Boston University, Boston, Massachusetts.

James Stevermer (J)

University of Missouri, Columbia.

Chien-Wen Tseng (CW)

University of Hawaii, Honolulu.
Pacific Health Research and Education Institute, Honolulu, Hawaii.

John B Wong (JB)

Tufts University School of Medicine, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH